Reports
Global Stem Cell Banking Market Size, Growth, Report: By Source: Placental Stem Cells (PSCs), Human Embryo-Derived Stem Cells, Bone Marrow-Derived Stem Cells, Dental Pulp-Derived Stem Cells, Others; By Product; By Bank Type; By Services Type; By Utilization; By Applications; Regional Analysis; Supplier Landscape; 2023-2031
Global Stem Cell Banking Market Outlook
The global stem cell banking market reached a value of about USD 8.4 billion in 2020. The market is further expected to grow at a CAGR of 13.5% in the forecast period of 2023-2028.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Demand for Adult Stem Cells to Augment the Stem Cell Banking Industry Growth
Based on product type, the adult stem cells segment accounts for a significant share in the industry. This can be attributed to the advantages offered by adult stem cells like their ability to repair damaged tissues through cell division, high acceptance in the human body and effectiveness in tissue generation, and ease of harvesting, among others.
North America Dominates the Stem Cell Banking Industry Globally
Geographically, North America leads the global market for stem cell banking. This can be attributed to the presence of advanced medical infrastructure and the increased government funding for stem cell research in the region. Additionally, the increased consumer awareness regarding the therapeutic benefits of stem cells is further aiding the market growth in the region. Meanwhile, the Asia Pacific is expected to witness a robust growth in the forecast period owing to the growing research activities in the region, coupled with the presence of a large pool of patient.
Stem Cell Banking: Market Segmentation
Stem cells refer to the highly specialised body cells that serve as a foundation for organ and tissues in the body. The properties of stem cells like self-renovation and differentiation make them different from other cells of the body. They can be found in the bone marrow, umbilical cord, embryo, and placenta. Stem cell banks are used to preserve these cells for potential future use in applications like regenerative medicine, gene therapy, and tissue engineering, among others. Stem cell banking is considered one of the most promising segments of the next-generation stem cell therapy.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By service type, the market is divided into:
- Sample Preservation and Storage
- Sample Analysis
- Sample Processing
- Sample Collection and Transportation
- Others
Based on product type, the industry can be segmented into:
- Human Embryonic Cells
- Adult Stem Cells
- IPS Cells
- Others
The market is bifurcated based on utilisation into:
- Used
- Unused
By bank type, the industry can be broadly categorised into:
- Public
- Private
On the basis of application, the industry can be segmented into:
- Clinical
- Personalised Banking
- Research
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Advancements in Medical Science and the Rising Prevalence of Chronic Diseases to Bolster the Growth of the Stem Cell Banking Industry
The advancements in the field of medicine and the development of novel technologies for preservation, processing, and storage of stem cells are driving the growth of the stem cell banking industry. Moreover, increasing cases of chronic diseases around the globe is resulting in increased demand for advanced medical technologies, which is further contributing to the industry growth. Other factors like the improving healthcare infrastructure, increasing geriatric population, and the rising disposable incomes are also favouring the market growth.
Over the forecast period, increasing R&D activities and the growing government initiatives to instill awareness about the therapeutic potentials of stem cells are expected to further accelerate the market growth.
Key Industry Players in the Global Stem Cell Banking Market
The report gives a detailed analysis of the following key players in the global stem cell banking market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Cryo-Cell International, Inc.
- Smart Cells International Ltd.
- CSG-BIO Company, Inc.
- CBR Systems Inc.
- ViaCord, LLC
- LifeCell International Pvt. Ltd.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Source |
|
| Breakup by Product |
|
| Breakup by Bank Type |
|
| Breakup by Services Type |
|
| Breakup by Utilization |
|
| Breakup by Applications |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Stem Cell Banking Market Overview
3.1 Global Stem Cell Banking Market Historical Value (2016-2022)
3.2 Global Stem Cell Banking Market Forecast Value (2023-2031)
4 Global Stem Cell Banking Market Landscape
4.1 Global Stem Cell Banking Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Stem Cell Banking Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Stem Cell Banking Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Stem Cell Banking Market Segmentation
6.1 Global Stem Cell Banking Market by Source
6.1.1 Market Overview
6.1.2 Placental Stem Cells (PSCs)
6.1.3 Human Embryo-Derived Stem Cells
6.1.4 Bone Marrow-Derived Stem Cells
6.1.5 Dental Pulp-Derived Stem Cells
6.1.6 Adipose Tissue-Derived Stem Cells
6.1.7 Other Stem Cell Sources
6.2 Global Stem Cell Banking Market by Product
6.2.1 Market Overview
6.2.2 Adult Stem Cells
6.2.3 Human Embryonic Cells
6.2.4 IPS Cells
6.2.5 Others
6.3 Global Stem Cell Banking Market by Bank Type
6.3.1 Market Overview
6.3.2 Private
6.3.3 Public
6.4 Global Stem Cell Banking Market by Services Type
6.4.1 Market Overview
6.4.2 Sample Collection and Transportation
6.4.3 Sample Processing, Sample Analysis
6.4.4 Sample Preservation, Storage
6.5 Global Stem Cell Banking Market by Utilization
6.5.1 Market Overview
6.5.2 Used
6.5.3 Unused
6.6 Global Stem Cell Banking Market by Applications
6.6.1 Market Overview
6.6.2 Personalized Storage
6.6.3 Clinical
6.6.4 Research
6.6.5 Others
6.7 Global Stem Cell Banking Market by Region
6.7.1 Market Overview
6.7.2 North America
6.7.3 Europe
6.7.4 Asia Pacific
6.7.5 Latin America
6.7.6 Middle East and Africa
7 North America Stem Cell Banking Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Stem Cell Banking Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Stem Cell Banking Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Stem Cell Banking Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Stem Cell Banking Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 CBR Systems, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Cordlife
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Cryo-Cell International, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 ViaCord
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Cryo-Save
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 LifeCell International Pvt. Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 StemCyte India Therapeutics Pvt. Ltd
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Global Cord Blood Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Smart Cells International Limited
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Caladrius Biosciences, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Celgene Corporation
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 BrainStorm Cell Limited
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Regrow Biosciences Pvt. Ltd.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 CryoHoldco
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Cryo-Save
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Stem Cell Banking Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
In 2020, the global stem cell banking market attained a value of nearly USD 8.4 billion.
The market is projected to grow at a CAGR of 13.5% between 2021 and 2026.
The major drivers of the market include increasing cases of chronic diseases, improving healthcare infrastructure, increasing geriatric population, and the rising disposable incomes.
Growing emphasis on research and development by key players and the growing government initiatives to instil awareness about the therapeutic potentials of stem cells are the key industry trends propelling the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with the North America accounting for the largest share.
The service types include sample preservation and storage, sample analysis, sample processing, sample collection and transportation, among others.
Adult stem cells are the largest product type segments of stem cell banking.
The segments based on utilisation are used and unused.
The bank types of stem cell banking are public and private.
The diverse applications for market are clinical, personalised banking, and research, among others.
The major players in the industry are Cryo-Cell International, Inc., Smart Cells International Ltd., CSG-BIO Company, Inc., CBR Systems Inc., ViaCord, LLC, and LifeCell International Pvt. Ltd. among others.
Analyst Review
The global stem cell banking market attained a value of USD 8.4 billion in 2020, driven by the rising healthcare expenditure. Aided by the growing technological advancements, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 13.5%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its product types, the stem cell banking industry can be segmented into human embryonic cells, adult stem cells and IPS cells, with the adult stem cells accounting for the largest part of market. The service types consist of sample preservation and storage, sample analysis, sample processing, sample collection, and transportation, among others. The classification based on utilisation are used and unused. The bank types are bifurcated into public and private. On the basis of applications, the industry is divided into clinical, personalised banking, and research, among others. The major regional markets for stem cell banking are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with the North America accounting for the greatest market share. The key players in the above market include Cryo-Cell International, Inc., Smart Cells International Ltd., CSG-BIO Company, Inc., CBR Systems Inc., ViaCord, LLC, and LifeCell International Pvt. Ltd., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER